Detalhe da pesquisa
1.
RHEB is a potential therapeutic target in T cell acute lymphoblastic leukemia.
Biochem Biophys Res Commun
; 621: 74-79, 2022 09 17.
Artigo
Inglês
| MEDLINE | ID: mdl-35810594